-+ 0.00%
-+ 0.00%
-+ 0.00%

Intensity Therapeutics Inc. Outlines 2026 Strategy: Pursuing Additional Peer-Reviewed Publications, Advancing Regulatory Engagement, Opportunistically Raising Capital, and Planning Phase 3 Breast Cancer Study Initiation

Reuters·01/13/2026 12:47:14

Please log in to view news